This Weight-Loss Drug ‘Dark Horse’ Could Take You for a Ride

Life Science

Can Palantir Justify Its 100x P/E? Mixed Signals from Institutional Investors Fuel Debate

Technology

Nvidia Stock Falls to Yearly Low, Historical Data Suggests Potential to Double

Technology

Is QuantumScape a Buy After Its 63% Plunge From Last Year’s High?

Technology

Forget AI and Weight-Loss Drugs: Why Vertex Pharmaceuticals Is the Silent Compounder You Need

Life Science

Lessons from History: $80 Silver May Not Be a Bargain

Mining, Precious Metals

Outpacing Inflation and Recession? These Three “Dividend Kings” Are Highly Anticipated for 2026

Consumer Goods, Financial Service, Technology

Stop Focusing Solely on Tech Stocks! Three Leading Infrastructure ETFs to Tap into America’s “Golden Decade” of Infrastructure Development

Financial Service

Will One Comment from Eli Lilly Turn Around Novo Nordisk’s Stock?

Life Science

OpenAI Reveals Ambitious Blueprint, Doubles Down on Hardware Development

Technology

Funds Accelerate Exodus from US? Emerging Market Assets See Strong Surge

Financial Service, Technology

Simplify Your Investment Strategy: Four Low-Cost ETFs to Watch in February

Financial Service, Technology

Is the Current US Stock Market Lacking Bargains? These Two High-Yield Dividend Stocks Are Worth Watching

Energy, Life Science

Can AMD’s Stock Take Off After Hibernation? Three Outlooks for AMD in 2026

Technology

Under the Rotation in the Canadian Stock Market, These Three Stocks Deserve Attention

Energy